At Arbor, we envision a world free of disease by using genetic medicines to fundamentally shift the paradigm from treatment to functional cure, and ultimately to prevention. We aim to accomplish this through the development of programmable DNA editors with the power to enable bespoke genetic medicines for patients.<\/p>\n
United by this shared vision and driven by a passion to deliver for patients, we have amassed one of the most talented and dedicated teams in the field to continue building upon the groundbreaking work of our founders.<\/p>\n
The result is a wholly owned portfolio of proprietary DNA editors capable of addressing more than 90% of the human genome, enabling us to select the optimal gene editing approach for each disease and unlocking opportunities to treat a broad range of diseases. We believe this approach can yield medicines with the potential to put functional cures within reach for patients.<\/p>\n","protected":false},"excerpt":{"rendered":"